Open AccessAnticonvulsant therapy in brain-tumor related epilepsy
Author(s) -
W. Fröscher,
Timo Kirschstein,
Johannes Rösche
Publication year - 2016
Publication title -
journal of epileptology
Language(s) - English
Resource type - Journals
eISSN - 2299-9728
pISSN - 2300-0147
DOI - 10.1515/joepi-2016-0004
Subject(s) - levetiracetam , medicine , epilepsy , tolerability , brain tumor , anticonvulsant , intensive care medicine , drug , oncology , bioinformatics , pharmacology , adverse effect , psychiatry , biology
Background. The lifetime risk of patients with brain tumors to have focal epileptic seizures is 10-100%; the risk depends on different histology. Specific guidelines for drug treatment of brain tumor-related seizures have not yet been established
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom